Symbols / EXAS $104.91 +0.00% Exact Sciences Corp

Healthcare • Diagnostics & Research • United States • NCM
EXAS Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Test;OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University, as well as Freenome Holdings, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Fundamentals
Scroll to Statements
Market Cap 20.03B Enterprise Value 21.60B Income -207.95M Sales 3.25B Book/sh 12.58 Cash/sh 5.05
Dividend Yield — Payout 0.00% Employees 7100 IPO Jan 31, 2001 P/E — Forward P/E 55.22
PEG — P/S 6.17 P/B 8.34 P/C — EV/EBITDA 302.23 EV/Sales 6.65
Quick Ratio 1.97 Current Ratio 2.43 Debt/Eq 105.57 LT Debt/Eq — EPS (ttm) -1.10 EPS next Y 1.90
EPS Growth — Revenue Growth 23.10% Earnings 2026-05-07 ROA -1.59% ROE -8.66% ROIC —
Gross Margin 69.69% Oper. Margin -9.28% Profit Margin -6.40% Shs Outstand 190.89M Shs Float 188.45M Short Float 3.92%
Short Ratio 3.23 Short Interest — 52W High 104.98 52W Low 38.81 Beta 1.44 Avg Volume 2.47M
Volume 21.56M Target Price $106.30 Recom Hold Prev Close $104.91 Price $104.91 Change 0.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$106.30
Mean price target
2. Current target
$104.91
Latest analyst target
3. DCF / Fair value
$26.58
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$104.91
Low
$105.00
High
$118.00
Mean
$106.30

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-20 down Mizuho Outperform → Neutral $105
2026-01-05 down Evercore ISI Group Outperform → In-Line $105
2025-11-28 down Stifel Buy → Hold $105
2025-11-25 down Canaccord Genuity Buy → Hold $105
2025-11-24 down Benchmark Buy → Hold —
2025-11-24 down Jefferies Buy → Hold $105
2025-11-21 down Wells Fargo Overweight → Equal-Weight $105
2025-11-21 down William Blair Outperform → Market Perform —
2025-11-21 down Guggenheim Buy → Neutral —
2025-11-21 down Barclays Overweight → Equal-Weight $105
2025-11-20 down BTIG Buy → Neutral —
2025-11-11 main Piper Sandler Overweight → Overweight $80
2025-11-05 main Wells Fargo Overweight → Overweight $85
2025-11-04 main TD Cowen Buy → Buy $90
2025-11-04 main Baird Outperform → Outperform $88
2025-11-04 main Benchmark Buy → Buy $75
2025-11-04 main Guggenheim Buy → Buy $75
2025-11-04 main Barclays Overweight → Overweight $77
2025-11-04 main Stifel Buy → Buy $80
2025-11-04 main BTIG Buy → Buy $85
News
RSS: Latest EXAS news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-23 CONDELLA SARAH K Officer — 60,389 $0.00 $0
2026-03-23 BARANICK BRIAN Officer — 33,321 $0.00 $0
2026-03-23 BLOOMER AARON Chief Financial Officer — 89,911 $0.00 $0
2026-03-23 ORVILLE JACOB A Officer — 53,323 $0.00 $0
2026-03-23 CONROY KEVIN T Chief Executive Officer — 119,312 $0.00 $0
2026-02-27 CONROY KEVIN T Chief Executive Officer — 68,097 — —
2026-02-27 CONDELLA SARAH K Officer — 3,900 $5.03 $19,617
2026-02-25 CONROY KEVIN T Chief Executive Officer — 13,181 $0.00 $0
2025-12-24 BARANICK BRIAN Officer — 92,523 $0.00 $0
2025-12-23 ORVILLE JACOB A Officer — 73,080 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
3,246.99
+17.69%
2,758.87
+10.37%
2,499.77
+19.93%
2,084.28
Operating Revenue
3,246.99
+17.69%
2,758.87
+10.37%
2,499.77
+19.93%
2,084.28
Cost Of Revenue
984.24
+17.15%
840.15
+13.91%
737.56
+11.52%
661.36
Reconciled Cost Of Revenue
984.24
+17.15%
840.15
+13.91%
737.56
+11.52%
661.36
Gross Profit
2,262.76
+17.93%
1,918.72
+8.88%
1,762.20
+23.84%
1,422.92
Operating Expense
2,461.85
+17.35%
2,097.96
+6.14%
1,976.59
-1.19%
2,000.46
Research And Development
523.00
+21.29%
431.21
+1.00%
426.93
+8.30%
394.19
Selling General And Administration
1,938.86
+15.69%
1,675.95
+2.94%
1,628.09
+2.20%
1,593.03
Selling And Marketing Expense
1,050.18
+17.45%
894.12
+8.01%
827.80
-10.95%
929.64
General And Administrative Expense
888.67
+13.67%
781.83
-2.31%
800.29
+20.64%
663.38
Salaries And Wages
—
1,001.40
+2.41%
977.80
-1.18%
989.50
Other Gand A
888.67
+13.67%
781.83
-2.31%
800.29
+20.64%
663.38
Other Operating Expenses
—
-9.20
+88.27%
-78.43
-692.17%
13.24
Total Expenses
3,446.09
+17.29%
2,938.11
+8.25%
2,714.16
+1.97%
2,661.82
Operating Income
-199.10
-11.08%
-179.24
+16.39%
-214.39
+62.88%
-577.54
Total Operating Income As Reported
-206.30
+80.33%
-1,048.70
-387.74%
-215.01
+63.77%
-593.51
EBITDA
52.44
+106.64%
-789.33
-2795.52%
29.28
+106.95%
-421.11
Normalized EBITDA
17.87
-41.06%
30.32
+330.87%
-13.13
+96.60%
-385.71
Reconciled Depreciation
221.58
+3.13%
214.86
+3.99%
206.61
+4.58%
197.56
EBIT
-169.14
+83.16%
-1,004.19
-466.30%
-177.32
+71.34%
-618.66
Total Unusual Items
34.57
+104.22%
-819.65
-2032.40%
42.42
+219.84%
-35.39
Total Unusual Items Excluding Goodwill
34.57
+104.22%
-819.65
-2032.40%
42.42
+219.84%
-35.39
Special Income Charges
-7.20
+99.16%
-859.21
-8955.06%
9.70
+160.76%
-15.97
Other Special Charges
—
-10.25
+0.68%
-10.32
—
Impairment Of Capital Assets
7.20
-99.17%
869.46
+139909.66%
0.62
-96.11%
15.97
Net Income
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Pretax Income
-203.89
+80.32%
-1,036.16
-413.60%
-201.75
+68.11%
-632.57
Net Non Operating Interest Income Expense
-39.36
-5.61%
-37.27
-25.19%
-29.77
-51.63%
-19.63
Interest Expense Non Operating
34.75
+8.69%
31.97
+30.93%
24.42
+75.60%
13.91
Net Interest Income
-39.36
-5.61%
-37.27
-25.19%
-29.77
-51.63%
-19.63
Interest Expense
34.75
+8.69%
31.97
+30.93%
24.42
+75.60%
13.91
Other Income Expense
34.57
+104.22%
-819.65
-2032.40%
42.42
+219.84%
-35.39
Gain On Sale Of Security
41.77
+5.59%
39.56
+20.92%
32.71
+268.41%
-19.43
Tax Provision
4.06
+155.60%
-7.30
-403.95%
2.40
+126.51%
-9.06
Tax Rate For Calcs
0.00
+3400.00%
0.00
-97.14%
0.00
+1515.38%
0.00
Tax Effect Of Unusual Items
7.26
+247.62%
-4.92
-155.21%
8.91
+2035.87%
-0.46
Net Income Including Noncontrolling Interests
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Net Income From Continuing Operation Net Minority Interest
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Net Income From Continuing And Discontinued Operation
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Net Income Continuous Operations
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Normalized Income
-235.26
-9.87%
-214.13
+9.90%
-237.66
+59.62%
-588.57
Net Income Common Stockholders
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Diluted EPS
-1.10
+80.32%
-5.59
-394.69%
-1.13
+68.08%
-3.54
Basic EPS
-1.10
+80.32%
-5.59
-394.69%
-1.13
+68.08%
-3.54
Basic Average Shares
188.69
+2.44%
184.20
+2.25%
180.14
+2.15%
176.35
Diluted Average Shares
188.69
+2.44%
184.20
+2.25%
180.14
+2.15%
176.35
Diluted NI Availto Com Stockholders
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Amortization
—
7.70
-91.64%
92.16
-5.43%
97.45
Amortization Of Intangibles Income Statement
—
7.70
-91.64%
92.16
-5.43%
97.45
Depreciation Amortization Depletion Income Statement
—
7.70
-91.64%
92.16
-5.43%
97.45
Depreciation And Amortization In Income Statement
—
7.70
-91.64%
92.16
-5.43%
97.45
Total Other Finance Cost
4.61
-12.97%
5.30
-1.01%
5.35
-6.58%
5.73
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
5,860.63
-1.14%
5,928.14
-8.39%
6,471.33
+3.93%
6,226.87
Current Assets
1,555.85
-0.99%
1,571.42
+31.57%
1,194.37
+21.59%
982.26
Cash Cash Equivalents And Short Term Investments
964.71
-7.06%
1,038.03
+33.48%
777.64
+23.03%
632.06
Cash And Cash Equivalents
956.00
+59.10%
600.89
-0.74%
605.38
+149.65%
242.49
Cash Equivalents
0.00
-100.00%
5.34
-92.90%
75.28
+17.03%
64.33
Cash Financial
956.00
+60.52%
595.55
+12.35%
530.10
+197.53%
178.17
Other Short Term Investments
8.71
-98.01%
437.14
+153.76%
172.27
-55.78%
389.56
Receivables
298.65
+19.96%
248.97
+22.27%
203.62
+28.84%
158.04
Accounts Receivable
298.65
+19.96%
248.97
+22.27%
203.62
+28.84%
158.04
Inventory
166.20
+2.35%
162.38
+27.38%
127.47
+7.79%
118.26
Raw Materials
75.72
+8.58%
69.73
+19.01%
58.59
-4.27%
61.21
Work In Process
90.48
-2.34%
92.65
+34.51%
68.88
+20.74%
57.05
Finished Goods
—
—
—
57.05
Prepaid Assets
—
—
—
—
Other Current Assets
126.28
+3.47%
122.05
+42.53%
85.63
+15.87%
73.90
Total Non Current Assets
4,304.78
-1.19%
4,356.72
-17.44%
5,276.97
+0.62%
5,244.62
Net PPE
831.00
+2.51%
810.62
-3.73%
842.06
-1.14%
851.76
Gross PPE
1,435.12
+8.79%
1,319.20
+4.76%
1,259.27
+8.62%
1,159.35
Accumulated Depreciation
-604.13
-18.79%
-508.57
-21.90%
-417.20
-35.64%
-307.59
Properties
0.00
0.00
0.00
0.00
Land And Improvements
11.46
-0.06%
11.46
+0.16%
11.45
+2.80%
11.13
Buildings And Improvements
290.78
+0.00%
290.78
+0.00%
290.78
+0.64%
288.94
Machinery Furniture Equipment
668.91
+14.73%
583.06
+17.98%
494.18
+16.75%
423.29
Construction In Progress
84.14
-5.53%
89.06
-14.85%
104.59
+52.92%
68.40
Other Properties
122.33
+4.60%
116.95
-18.62%
143.71
-13.95%
167.00
Leases
257.50
+13.00%
227.88
+6.21%
214.56
+6.97%
200.59
Goodwill And Other Intangible Assets
3,287.97
-2.62%
3,376.37
-20.70%
4,257.52
-1.04%
4,302.28
Goodwill
2,368.05
+0.06%
2,366.68
-0.02%
2,367.12
+0.90%
2,346.04
Other Intangible Assets
919.92
-8.89%
1,009.69
-46.59%
1,890.40
-3.37%
1,956.24
Other Non Current Assets
185.81
+9.48%
169.72
-4.32%
177.39
+95.84%
90.58
Total Liabilities Net Minority Interest
3,459.58
-1.88%
3,525.89
+6.01%
3,326.03
+4.47%
3,183.71
Current Liabilities
641.15
-12.43%
732.19
+42.25%
514.70
+24.70%
412.75
Payables And Accrued Expenses
315.68
+36.11%
231.93
+34.16%
172.88
+0.00%
172.88
Payables
175.87
+96.34%
89.57
+13.65%
78.82
+5.21%
74.92
Accounts Payable
175.87
+96.34%
89.57
+13.65%
78.82
+5.21%
74.92
Current Accrued Expenses
139.81
-1.79%
142.36
+51.34%
94.06
-3.98%
97.96
Pensionand Other Post Retirement Benefit Plans Current
276.66
+48.79%
185.93
-24.91%
247.62
+23.04%
201.25
Current Debt And Capital Lease Obligation
33.59
-87.85%
276.56
+248.40%
79.38
+179.84%
28.37
Current Debt
—
249.15
+398.31%
50.00
—
Other Current Borrowings
—
249.15
+398.31%
50.00
—
Current Capital Lease Obligation
33.59
+22.57%
27.41
-6.72%
29.38
+3.57%
28.37
Other Current Liabilities
15.22
-59.70%
37.77
+154.77%
14.82
+44.63%
10.25
Total Non Current Liabilities Net Minority Interest
2,818.43
+0.88%
2,793.70
-0.63%
2,811.33
+1.46%
2,770.96
Long Term Debt And Capital Lease Obligation
2,489.11
+0.44%
2,478.20
+0.12%
2,475.35
+2.35%
2,418.51
Long Term Capital Lease Obligation
161.93
+3.05%
157.13
-2.44%
161.07
-11.69%
182.40
Other Non Current Liabilities
329.32
+4.38%
315.50
-6.10%
335.98
-4.67%
352.46
Stockholders Equity
2,401.05
-0.05%
2,402.25
-23.62%
3,145.30
+3.36%
3,043.16
Common Stock Equity
2,401.05
-0.05%
2,402.25
-23.62%
3,145.30
+3.36%
3,043.16
Capital Stock
1.91
+2.80%
1.86
+2.31%
1.81
+1.97%
1.78
Common Stock
1.91
+2.80%
1.86
+2.31%
1.81
+1.97%
1.78
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
190.80
+2.79%
185.62
+2.34%
181.36
+1.93%
177.93
Ordinary Shares Number
190.80
+2.79%
185.62
+2.34%
181.36
+1.93%
177.93
Additional Paid In Capital
7,102.77
+2.95%
6,899.37
+4.36%
6,611.24
+4.75%
6,311.64
Retained Earnings
-4,705.98
-4.62%
-4,498.03
-29.66%
-3,469.18
-6.25%
-3,265.03
Gains Losses Not Affecting Retained Earnings
2.36
+349.79%
-0.94
-166.11%
1.43
+127.27%
-5.24
Other Equity Adjustments
2.36
+349.79%
-0.94
-166.11%
1.43
+127.27%
-5.24
Total Equity Gross Minority Interest
2,401.05
-0.05%
2,402.25
-23.62%
3,145.30
+3.36%
3,043.16
Working Capital
914.70
+8.99%
839.24
+23.48%
679.67
+19.34%
569.51
Invested Capital
4,728.23
-4.91%
4,972.47
-9.75%
5,509.58
+4.36%
5,279.27
Total Debt
2,522.70
-8.42%
2,754.76
+7.83%
2,554.72
+4.41%
2,446.87
Net Debt
1,371.18
-30.37%
1,969.33
+11.96%
1,758.90
-11.77%
1,993.61
Capital Lease Obligations
195.52
+5.95%
184.54
-3.10%
190.45
-9.64%
210.76
Net Tangible Assets
-886.92
+8.95%
-974.12
+12.42%
-1,112.21
+11.67%
-1,259.12
Tangible Book Value
-886.92
+8.95%
-974.12
+12.42%
-1,112.21
+11.67%
-1,259.12
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
491.44
+133.42%
210.54
+34.86%
156.12
+169.83%
-223.56
Cash Flow From Continuing Operating Activities
491.44
+133.42%
210.54
+34.86%
156.12
+169.83%
-223.56
Net Income From Continuing Operations
-207.95
+79.79%
-1,028.86
-403.97%
-204.15
+67.26%
-623.51
Depreciation Amortization Depletion
221.58
+3.13%
214.86
+3.99%
206.61
+4.58%
197.56
Depreciation
124.88
+4.33%
119.70
+4.59%
114.45
+14.32%
100.11
Amortization Cash Flow
96.70
+1.62%
95.16
+3.25%
92.16
-5.43%
97.45
Depreciation And Amortization
221.58
+3.13%
214.86
+3.99%
206.61
+4.58%
197.56
Amortization Of Intangibles
96.70
+1.62%
95.16
+3.25%
92.16
-5.43%
97.45
Other Non Cash Items
135.74
+879.31%
13.86
+122.16%
-62.55
-264.90%
-17.14
Stock Based Compensation
217.67
+1.29%
214.88
-7.10%
231.31
+11.84%
206.82
Asset Impairment Charge
7.20
-99.17%
869.46
+139909.66%
0.62
-96.11%
15.97
Deferred Tax
-1.54
+84.74%
-10.12
-959.58%
-0.95
+91.98%
-11.90
Deferred Income Tax
-1.54
+84.74%
-10.12
-959.58%
-0.95
+91.98%
-11.90
Operating Gains Losses
-3.08
+59.14%
-7.54
+47.71%
-14.42
-141.18%
35.02
Gain Loss On Investment Securities
-3.08
-213.56%
2.71
+166.20%
-4.10
-118.82%
21.77
Unrealized Gain Loss On Investment Securities
—
—
—
11.77
Gain Loss On Sale Of PPE
—
—
—
1.86
Change In Working Capital
121.83
+317.50%
-56.01
-16277.78%
-0.34
+98.70%
-26.38
Change In Receivables
-48.89
-5.69%
-46.26
-6.55%
-43.42
-171.07%
61.09
Changes In Account Receivables
-48.89
-5.69%
-46.26
-6.55%
-43.42
-171.07%
61.09
Change In Inventory
-3.77
+89.20%
-34.91
-353.98%
-7.69
+41.88%
-13.23
Change In Payables And Accrued Expense
214.04
+391.62%
43.54
-47.39%
82.75
+258.59%
-52.18
Change In Other Working Capital
—
—
—
-1.41
Change In Other Current Assets
-5.79
-149.42%
-2.32
+80.01%
-11.62
-13730.95%
-0.08
Change In Other Current Liabilities
-33.76
-110.25%
-16.06
+21.17%
-20.37
+7.29%
-21.97
Investing Cash Flow
195.12
+144.13%
-442.15
-990.02%
49.68
-32.93%
74.07
Cash Flow From Continuing Investing Activities
195.12
+144.13%
-442.15
-990.02%
49.68
-32.93%
74.07
Net PPE Purchase And Sale
-134.66
+0.98%
-135.99
-9.50%
-124.19
+42.09%
-214.46
Purchase Of PPE
-134.66
+0.98%
-135.99
-9.50%
-124.19
+42.09%
-214.46
Capital Expenditure
-134.66
+0.98%
-135.99
-9.50%
-124.19
+42.09%
-214.46
Net Investment Purchase And Sale
376.51
+244.29%
-260.94
-215.19%
226.53
-18.74%
278.76
Purchase Of Investment
-195.77
+58.06%
-466.76
-198.41%
-156.42
+10.26%
-174.31
Sale Of Investment
572.28
+178.05%
205.82
-46.25%
382.95
-15.48%
453.07
Net Business Purchase And Sale
0.00
0.00
+100.00%
-52.41
-256.89%
-14.69
Purchase Of Business
0.00
0.00
+100.00%
-52.41
-256.89%
-14.69
Net Other Investing Changes
-46.73
-3.33%
-45.23
-17990.00%
-0.25
-101.02%
24.45
Financing Cash Flow
-338.09
-245.81%
231.87
+45.13%
159.77
+108.89%
76.48
Cash Flow From Continuing Financing Activities
-338.09
-245.81%
231.87
+45.13%
159.77
+108.89%
76.48
Net Issuance Payments Of Debt
-249.17
-214.96%
216.75
+57.09%
137.98
+175.95%
50.00
Issuance Of Debt
0.00
-100.00%
266.75
+93.33%
137.98
+175.95%
50.00
Repayment Of Debt
-249.17
-398.34%
-50.00
0.00
0.00
Long Term Debt Issuance
0.00
-100.00%
266.75
+93.33%
137.98
+175.95%
50.00
Long Term Debt Payments
-249.17
-398.34%
-50.00
0.00
0.00
Net Long Term Debt Issuance
-249.17
-214.96%
216.75
+57.09%
137.98
+175.95%
50.00
Net Common Stock Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
28.45
-13.48%
32.88
+4.24%
31.54
-1.48%
32.02
Net Other Financing Charges
-117.36
-561.06%
-17.75
-82.07%
-9.75
-76.33%
-5.53
Changes In Cash
348.47
+136554.51%
0.26
-99.93%
365.56
+600.72%
-73.01
Effect Of Exchange Rate Changes
0.89
+127.05%
-3.29
-349.36%
1.32
+4303.33%
0.03
Beginning Cash Position
606.64
-0.50%
609.67
+151.11%
242.79
-23.11%
315.77
End Cash Position
956.00
+57.59%
606.64
-0.50%
609.67
+151.11%
242.79
Free Cash Flow
356.78
+378.60%
74.55
+133.48%
31.93
+107.29%
-438.02
Interest Paid Supplemental Data
30.44
+9.36%
27.84
+48.27%
18.78
+63.00%
11.52
Amortization Of Securities
—
—
—
1.84
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category